Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania is entering a new stage, with its multiannual economic recovery programme launching in 2026, carrying an estimated budget of around €5 billion through 2032 and a dedicated framework for anchor-type strategic investments above €200 million, according to experts at EY Romania.
OMV Petrom, an integrated energy producer in Southeast Europe, has made the final investment decision for Gabare, an integrated solar energy and battery storage project in Bulgaria.
The gap between European and Romanian agricultural economic pressures widened in Q1 2026.
More frequent heatwaves, rising energy costs and concerns about indoor air quality are changing the way Romanians choose climate control solutions.
Romania's annual inflation rate climbed to 10.85% in May from 10.71% in April, driven by rising costs across all sectors, according to data released by the National Institute of Statistics (INS).